TEVA241227C27000
- 0.00
- 0.000.00%
Teva Pharmaceutical Industries Newsroom
US Stock Gold Mining | AI applications are accelerating penetration! Palantir surged over 8% last Friday; positive news from new drug trials led Teva Pharmaceutical Industries to accumulate a rise of over 33% last week, and its stock price has doubled wit
Performance and guidance exceeded expectations, with multiple Analysts raising their Target Price! Darden Restaurants, the parent company of Olive Garden, rose over 2% on the previous Trading day, accumulating a gain of more than 12% last week. The Market Cap is firmly above 20 billion USD, and the stock price has reached a new high for the year!
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 A.m. ET on January 29, 2025
Teva Pharmaceutical Industries Options Spot-On: On December 20th, 113.39K Contracts Were Traded, With 981.61K Open Interest
On December 20th ET, $Teva Pharmaceutical Industries(TEVA.US)$ had active options trading, with a total trading volume of 113.39K options for the day, of which put options accounted for 6.39% of the
This week's US stock market hot stocks | The US version of HAIDILAO exceeds expectations! Darden Restaurants' stock price skyrocketed nearly 15%; Boeing, a component of the Dow, rose 4.36% against the trend this week, receiving a large order for 737 MAX a
This week, the Dow Jones Industrial Average has fallen by 3.39%, closing at 42,342.24 points; during the same period, the S&P 500 Index has decreased by 3.04%, closing at 5,867.08 points; the Nasdaq has dropped by 2.78%, closing at 19,372.77 points.
UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $28
Jim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Teva Pharmaceutical Stock Positioned for Even Better Performance in 2025, UBS Says
U.S. Supreme Court Agrees To Hear South Carolina's Bid To End Public Funding Of Abortion Provider Planned Parenthood
Teva Pharmaceutical Indus Analyst Ratings
FDA Approves Celltrion's Biosimilar of J&J's Stelara
Express News | Teva : BofA Global Research Raises Price Objective to $25 From $23
Daily short sale tracking: NVIDIA's short volume increased by 5 million, with a short sale ratio of 10%
NVIDIA(NVDA.US) ranked top of the list had the largest change in short volume (5.8 million shares), and the short volume ratio of Targa Resources(TRGP.US) reached 46.1%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study
Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $28
Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn Into More Strength?